7:40 AM - 8:40 AM
Registration & Refreshments
8:40 AM - 8:50 AM
8:50 AM - 9:25 AM - Keynote
Technology & Innovation
Emerging Opportunities in Drug Delivery: Overcoming Barriers for New Modalities
Anand Subramony, Vice President Novel Product Technologies, AstraZeneca
9:30 AM - 10:05 AM - Case Studies
Small Molecules
Mechanistic Pathways and Tools for Minimizing Drug Precipitation
Ajit Narang, Senior Principal Scientist, Genentech
Biologics
Advances in Biologics Delivery Across Epithelial Barriers
Device Development
The Challenges and Opportunities of Development of Combination Inhalation Products for Non-Pulmonary Diseases
Mick Hurrey, Vice President, Product Development, InCarda Therapeutics
10:10 AM - 10:45 AM - Solution Spotlights
Small Molecules
Universal Product Design for Drug Delivery--Concept to Commercialization Approach
Daniel Kuntz, Associate Principal Engineer, Lonza Pharma & Biotech
Device Development
Novel Device for the Subcutaneous Delivery of Large-Volume Biologics
Robert Kriftner, Product Manager, Gerresheimer AG
10:45 AM - 11:35 AM
1-to-1 Meetings & Networking Break
11:35 AM - 12:10 PM - Case Studies
Small Molecules
Phase-Appropriate Formulation Development – A Regulatory Perspective.
Biologics
Development, Manufacturing and Supply of Ebola Vaccine
Lynne Isopi, Principal Scientist, Vaccine Drug Product Development, Merck
Technology & Innovation
Merging Nanotechnology and Microfluidics to Develop Targeted Therapies
Hagar Labouta, Assistant Professor , University of Manitoba
12:15 PM - 12:50 PM - Solution Spotlights
Biologics
Polysorbates in Biopharmaceutical Formulations
Stephen Rumbelow, Research and Technology Manager R&D, Innovation Support and Health Care, Croda
Biologics
Keys to the Successful Development of High Quality Lipids, Critical for RNA Delivery and Vaccines
Estelle Beguin, Strategic Marketing Manager - Synthetic Lipids, MilliporeSigma
12:50 PM - 1:50 PM
Lunch Break
1:50 PM - 2:25 PM - Case Studies
Small Molecules
Recent Advances in Modified and Controlled Release Formulations
Biologics
Challenges and Opportunities in Cell Therapy Formulation and Delivery
Device Development
Vaccine Delivery via Microneedles
2:30 PM - 3:05 PM - Case Studies
Small Molecules
DepoFoam® Technology: A Controlled-Release Lipid-Based Drug Delivery Platform
Soroush Ardekani, Manager, Pacira Biosciences
Biologics
Disruptive Technologies for Formulation, Manufacturing and/or Delivery: Enabling Advancements for Biologics and Vaccines Products into the Future
Jeffrey T. Blue, Executive Director, Vaccine Drug Product Development PR&D, Merck
Device Development
The Confluence of Innovation in Therapeutics, Drug Delivery and Regulation
Twinkle Christian, Process Development Scientist, Drug Product Technologies Group , Amgen
3:05 PM - 3:55 PM
1-to-1 Meetings & Networking Break
3:55 PM - 4:30 PM - Solution Spotlights
Biologics
Vaccine Formulation and Manufacturing for High-Density Microarray Patches (HD-MAPs): Challenges in Replacing the Needle and Syringe
Dr. Angus Forster, Chief Development and Operations Officer, Vaxxas
Technology & Innovation
BEPO® - An Enabling Long Acting Injectable Technology Platform for Drug Delivery Challenges
Sylvestre Grizot, Principal Investigator, MedinCell
4:35 PM - 5:20 PM - Panel Discussion
Technology & Innovation
Preparing for Patient-Centric Drug Development Regulations
Dr. Jamie Unwin, Commercial Insights Officer, Nanoform
Hannah Mann, Founding Partner, Day One
Twinkle Christian, Process Development Scientist, Drug Product Technologies Group , Amgen
5:20 PM - 5:25 PM
8:00 AM - 8:45 AM
Registration & Refreshments
8:45 AM - 8:50 AM
8:50 AM - 9:25 AM - Keynote
Technology & Innovation
Biopredictive Tools for the Development of Injectable Drug Products
Matthias G. Wacker, Associate Professor, National University of Singapore
9:30 AM - 10:05 AM - Case Studies
Small Molecules
Drug Delivery Systems for Proteolysis Targeting Chimera that Improve Tumour Accumulation and Therapeutic Index
Vijay Anand Sethuraman, Senior Scientific Manager, Genentech
Biologics
Novel Technologies for Targeted Oral Peptide Delivery
Puneet Tyagi, Senior Scientist, AstraZeneca
Device Development
Improved Infusion: A New Device Aimed at Revolutionizing the Way Biologic Infusions are are Administered
Geoff Wise, Senior Manager Device Development, Genentech
10:10 AM - 10:45 AM - Solution Spotlights
Small Molecules
From Bench to Bedside – Why Small is Powerful® for Patients
David Rowe, Head of Manufacturing, Nanoform
Christian Jones, Chief Commercial Officer, Nanoform
Chris Roe, Senior Research Fellow, Quotient
Claire Wombwell, Senior Scientist, Johnson Matthey
Technology & Innovation
Nanotechnology for Delivery of Nucleic Acid Payloads
Andrea Cusack, CEO, Leon-Nanodrugs
10:45 AM - 11:35 AM
1-to-1 Meetings & Networking Break
11:35 AM - 12:10 PM - Case Studies
Small Molecules
Continuous Manufacturing of Pharmaceutical Nanoparticles (CM-NANO)
Luis Padrela, Lecturer, Department of Chemical Sciences, Bernal Institute, University of Limerick
Technology & Innovation
Novel Nanotechnologies for Mucosal Delivery of Small Molecules and Biologics: Old Problems but New Solutions
Andreas Bernkop- Schnurch, Professor, University of Innsbruck
12:15 PM - 12:50 PM - Solution Spotlights
Small Molecules
Multiparticulates: A Versatile System for Pulsatile Release
12:50 PM - 1:50 PM
Lunch Break
1:50 PM - 2:25 PM - Case Studies
Small Molecules
Engineering Technologies for Drug Product Development
Srinivas Tummala, Senior Director, Pharmaceutical Development Leader, BMS
Technology & Innovation
Lyophilization and Stability of AAV-based Gene Therapy – Challenges and Opportunities
Zoe Zhang, Scientist II , REGENXBIO Inc.
2:30 PM - 3:05 PM - Keynote
Technology & Innovation
Successes and Challenges in Crystal Structure Prediction (CSP) in Discovery Drug Design and Developability Assessment
Faraj Atassi, Director of Pharmaceutical Development, AstraZeneca
3:05 PM - 3:20 PM
Networking Break
3:20 PM - 3:55 PM - Keynote
Technology & Innovation
Long Acting Injectables – Design and Delivery
Manish Gupta, Senior Director, Sterile Drug Product Development, Pharmaceutical Development, GSK
4:00 PM - 4:35 PM - Case Studies
Small Molecules
Life Cycle Management: Developing and Bringing Innovative Medicines to Market
Rosario LoBrutto, Head of Scientific Affairs, Sandoz
4:35 PM - 4:40 PM